$LTBR

Chakraborty Sweta sold $11K of LTBR

Chakraborty Sweta sold 1,143 shares of LIGHTBRIDGE Corp (LTBR) at $9.29 on 2026-07-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Chakraborty Sweta
Published Jul 2, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 7:22 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$LTBR
Neutral
medium confidence
Mentioned
$LTBR
Relevance
2/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LTBRNeutralLow
01

Why it matters

A director’s open-market sale under a Rule 10b5-1 plan is generally not a fundamental catalyst; it mainly updates insider activity records.

02

Market read

Traders may note insider selling activity, but the pre-arranged nature limits actionable signal strength.

03

What to watch

Because the transaction is under a pre-arranged 10b5-1 plan, it may not coincide with any new information; also, the article provides no buy-side counterpart or follow-on corporate catalyst.

Relevance 2/10Novelty 3/10Timing: Filed 2026-07-02, covering a sale executed 2026-07-01.

Background

The article is an SEC Form 4 insider transaction disclosure for Lightbridge Corp (LTBR).

Company-level read

Ticker impact

$LTBRNeutralMedium confidence
Context

Lightbridge director Sweta Chakraborty sold 1,143 shares in an open-market transaction at $9.29 on 2026-07-01 under a 10b5-1 plan.

Expected impact

Likely minimal immediate impact; any effect would be sentiment-only and short-lived.

Evidence & confidence

The filing is a Form 4 insider transaction, but it explicitly references a pre-arranged Rule 10b5-1 plan, which typically reduces interpretability as new negative information.

Market effects

No clear sector read-through from a single director 10b5-1 sale.

None indicated.

None indicated.

Counterpoint

The sale could still reflect personal liquidity needs rather than any view on business prospects, so it may be over-weighted by traders.

Key entities

  • LIGHTBRIDGE Corp

    Company whose director insider sale is disclosed on Form 4.

  • Chakraborty Sweta

    Director who sold 1,143 shares on 2026-07-01 under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LTBRMed

Lightbridge (LTBR) Q2 2026 Earnings Call Transcript

Lightbridge (LTBR) held its Q2 2026 earnings call, reporting cash of $237.5M and working capital of $236.4M as of June 30, 2026, versus $201.9M and $201.7M at end-2025. Net loss was $5.8M for Q2 and $12.1M for the first half. It generated $43.9M net cash from an ATM facility and discussed fuel milestones, software partnerships, and a HALEU supply MoU with Centrus Energy.

$LTBRMed

LIGHTBRIDGE Corp (LTBR): Results of Operations and Financial Condition

LIGHTBRIDGE Corp (LTBR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 Lightbridge Provides Business Update and Announces First Half Fiscal 2026 Financial Results RESTON, Va., August 5, 2026 (GLOBE NEWSWIRE) – Lightbridge Corporation (“Lightbridge” or the “Company”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, announced

$LTBRMed

TRISO approval, HALEU pact advance US nuclear fuel

Framatome said the US NRC approved a licence amendment raising enrichment at materials licence SNM-1227 from 6.5 wt% U-235 to under 10% and authorising TRISO fuel fabrication at its Richland site. The approval supports Standard Nuclear-Framatome’s plan to start UO2 powder and TRISO particle manufacturing in 2027. Separate MoUs cover HALEU supply talks between Lightbridge and QNI.